Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-κB Signaling

by Yamel Cardona Gloria, Yamel Cardona Gloria, Stephan H. Bernhart, Stephan H. Bernhart, Stephan H. Bernhart, Sven Fillinger, Olaf-Oliver Wolz, Olaf-Oliver Wolz, Sabine Dickhöfer, Sabine Dickhöfer, Jakob Admard, Stephan Ossowski, Sven Nahnsen, Reiner Siebert, Reiner Siebert, Alexander N. R. Weber, Alexander N. R. Weber, Alexander N. R. Weber
Published 2021-06-01

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

by Annika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, Heiko Schuster, Olaf-Oliver Wolz, Janet Kerstin Peper, Yamel Cardona Gloria, Anton W. Langerak, Alice F. Muggen, Rainer Claus, Irina Bonzheim, Falko Fend, Helmut Rainer Salih, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanović, Alexander N. R. Weber
Published 2017-03-01